This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BigCommerce (BIGC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
BigCommerce (BIGC) delivered earnings and revenue surprises of 46.15% and 0.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -90.48% and 7.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amazon (AMZN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Amazon (AMZN) delivered earnings and revenue surprises of 40% and 2.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ETFs & Stocks to Win Despite a Soft December Retail Sales
by Sanghamitra Saha
Retail sales in the United States fell 1.1% sequentially in December 2022. Year-over-year, retail sales grew 9.2%.
PetMed (PETS) Misses Q2 Earnings Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -51.85% and 0.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
November Retail Sales Steady: 3 ETF & Stock Picks
by Sanghamitra Saha
3 ETF and stocks to play the surge in retail sales in November.
Earnings Preview: Amazon (AMZN) Q3 Earnings Expected to Decline
by Zacks Equity Research
Amazon (AMZN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pet Industry Seems Recession-Proof: ETF & Stocks in Focus
by Sanghamitra Saha
American Pet Products Association, 70% of U.S. households own a pet, as quoted on Yahoo Finance. And Americans are splurging on their pets despite high inflation.
Analysts Estimate PetMed (PETS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetMed (PETS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Invest Like Value Stock Gurus
by Tracey Ryniec
What are the Buffett and Graham-like stocks in 2022?
PetMed (PETS) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -46.15% and 13.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Q4 Earnings Top Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of 11.11% and 2.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cars.com (CARS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cars.com (CARS) delivered earnings and revenue surprises of 100% and 0.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -30% and 1.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Consider PetMed (PETS) Stock Now?
by Zacks Equity Research
Let's see if PetMed (PETS) stock is a good choice for value-oriented investors right now from multiple angles.
Analysts Estimate PetMed (PETS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetMed (PETS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CarMax (KMX) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CarMax (KMX) delivered earnings and revenue surprises of 3.38% and 8.07%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Winnebago, IBM, Facebook and PetMed Express highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Winnebago, IBM, Facebook and PetMed Express highlighted as Zacks Bull and Bear of the Day
Facebook (FB) Mixed on Troubled Quarter, PETS Misses
by Mark Vickery
No sell-the-news on Facebook earnings, even with the company having lowered its revenue guidance for next quarter.
Zacks Value Trader Highlights: Nintendo, Broadmark Realty Capital, DR Horton, Movado and Petmed Express
by Zacks Equity Research
Zacks Value Trader Highlights: Nintendo, Broadmark Realty Capital, DR Horton, Movado and Petmed Express
Value Investing Basics from Ben Graham
by Tracey Ryniec
Who is Ben Graham and why should value investors care?
Markets Close Flat, Await New Jobs Data
by Mark Vickery
Tomorrow brings us our first steady diet of useful economic data of the week, with both normal Thursday Initial Jobless Claims and ADP (ADP) private-sector payrolls.
Solid E-commerce Business Aids Alibaba (BABA), Risks Persist
by Zacks Equity Research
Alibaba Group Holding's (BABA) product launches, strength in core commerce and strong cloud business are likely to drive growth. However, antitrust hassles and higher costs remain concerns.
Shop These ETFs & Stocks This Valentine's Day
by Sanghamitra Saha
These investment areas and the related ETFs and stocks should benefit from the record splurge on Valentine's Day this year.
IDEXX's Kidney Function Test Included in IRIS Staging Views
by Zacks Equity Research
IDEXX (IDXX) is upbeat about the inclusion and approval of the SDMA-based renal care staging guidelines.